Literature DB >> 24163370

The HECT type ubiquitin ligase NEDL2 is degraded by anaphase-promoting complex/cyclosome (APC/C)-Cdh1, and its tight regulation maintains the metaphase to anaphase transition.

Li Lu1, Shaohua Hu, Rongfei Wei, Xiao Qiu, Kefeng Lu, Yesheng Fu, Hongchang Li, Guichun Xing, Dong Li, Ruiyun Peng, Fuchu He, Lingqiang Zhang.   

Abstract

NEDD4-like ubiquitin ligase 2 (NEDL2) is a HECT type ubiquitin ligase. NEDL2 enhances p73 transcriptional activity and degrades ATR kinase in lamin misexpressed cells. Compared with the important functions of other HECT type ubiquitin ligase, there is less study concerning the function and regulation of NEDL2. Using primary antibody immunoprecipitation and mass spectrometry, we identify a list of potential proteins that are putative NEDL2-interacting proteins. The candidate list contains many of mitotic proteins, especially including several subunits of anaphase-promoting complex/cyclosome (APC/C) and Cdh1, an activator of APC/C. Cdh1 can interact with NEDL2 in vivo and in vitro. Cdh1 recognizes one of the NEDL2 destruction boxes (R(740)GSL(743)) and targets it for degradation in an APC/C-dependent manner during mitotic exit. Overexpression of Cdh1 reduces the protein level of NEDL2, whereas knockdown of Cdh1 increases the protein level of NEDL2 but has no effect on the NEDL2 mRNA level. NEDL2 associates with mitotic spindles, and its protein level reaches a maximum in mitosis. The function of NEDL2 during mitosis is essential because NEDL2 depletion prolongs metaphase, and overexpression of NEDL2 induces chromosomal lagging. Elevated expression of NEDL2 protein and mRNA are both found in colon cancer and cervix cancer. We conclude that NEDL2 is a novel substrate of APC/C-Cdh1 as cells exit mitosis and functions as a regulator of the metaphase to anaphase transition. Its overexpression may contribute to tumorigenesis.

Entities:  

Keywords:  APC/C; Cell Cycle; Mitosis; Protein Degradation; Tumor; Ubiquitin Ligase

Mesh:

Substances:

Year:  2013        PMID: 24163370      PMCID: PMC3861616          DOI: 10.1074/jbc.M113.472076

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

1.  Mad2-Independent inhibition of APCCdc20 by the mitotic checkpoint protein BubR1.

Authors:  Z Tang; R Bharadwaj; B Li; H Yu
Journal:  Dev Cell       Date:  2001-08       Impact factor: 12.270

2.  Cdh1-APC controls axonal growth and patterning in the mammalian brain.

Authors:  Yoshiyuki Konishi; Judith Stegmüller; Takahiko Matsuda; Shirin Bonni; Azad Bonni
Journal:  Science       Date:  2004-01-08       Impact factor: 47.728

3.  A novel HECT-type E3 ubiquitin ligase, NEDL2, stabilizes p73 and enhances its transcriptional activity.

Authors:  Kou Miyazaki; Toshinori Ozaki; Chiaki Kato; Takayuki Hanamoto; Tomoyuki Fujita; Shigemi Irino; Ken-ichi Watanabe; Takahito Nakagawa; Akira Nakagawara
Journal:  Biochem Biophys Res Commun       Date:  2003-08-15       Impact factor: 3.575

4.  From spindle checkpoint to cancer.

Authors:  Christoph Lengauer; Zhenghe Wang
Journal:  Nat Genet       Date:  2004-11       Impact factor: 38.330

5.  The E3 ligase Cdh1-anaphase promoting complex operates upstream of the E3 ligase Smurf1 in the control of axon growth.

Authors:  Madhuvanthi Kannan; Shih-Ju Lee; Nicola Schwedhelm-Domeyer; Judith Stegmüller
Journal:  Development       Date:  2012-10       Impact factor: 6.868

6.  NEDL1, a novel ubiquitin-protein isopeptide ligase for dishevelled-1, targets mutant superoxide dismutase-1.

Authors:  Kou Miyazaki; Tomoyuki Fujita; Toshinori Ozaki; Chiaki Kato; Yuka Kurose; Maya Sakamoto; Shinsuke Kato; Takeshi Goto; Yasuto Itoyama; Masashi Aoki; Akira Nakagawara
Journal:  J Biol Chem       Date:  2003-12-18       Impact factor: 5.157

7.  Identification of a new APC/C recognition domain, the A box, which is required for the Cdh1-dependent destruction of the kinase Aurora-A during mitotic exit.

Authors:  Laurie E Littlepage; Joan V Ruderman
Journal:  Genes Dev       Date:  2002-09-01       Impact factor: 11.361

Review 8.  The spindle checkpoint, aneuploidy, and cancer.

Authors:  Rajnish Bharadwaj; Hongtao Yu
Journal:  Oncogene       Date:  2004-03-15       Impact factor: 9.867

Review 9.  The significance of unstable chromosomes in colorectal cancer.

Authors:  Harith Rajagopalan; Martin A Nowak; Bert Vogelstein; Christoph Lengauer
Journal:  Nat Rev Cancer       Date:  2003-09       Impact factor: 60.716

10.  Human securin proteolysis is controlled by the spindle checkpoint and reveals when the APC/C switches from activation by Cdc20 to Cdh1.

Authors:  Anja Hagting; Nicole Den Elzen; Hartmut C Vodermaier; Irene C Waizenegger; Jan-Michael Peters; Jonathon Pines
Journal:  J Cell Biol       Date:  2002-06-17       Impact factor: 10.539

View more
  16 in total

1.  Fission yeast Cactin restricts telomere transcription and elongation by controlling Rap1 levels.

Authors:  Luca E Lorenzi; Amadou Bah; Harry Wischnewski; Vadim Shchepachev; Charlotte Soneson; Marco Santagostino; Claus M Azzalin
Journal:  EMBO J       Date:  2014-11-14       Impact factor: 11.598

Review 2.  Functional characterization of Anaphase Promoting Complex/Cyclosome (APC/C) E3 ubiquitin ligases in tumorigenesis.

Authors:  Jinfang Zhang; Lixin Wan; Xiangpeng Dai; Yi Sun; Wenyi Wei
Journal:  Biochim Biophys Acta       Date:  2014-02-22

3.  De novo missense variants in HECW2 are associated with neurodevelopmental delay and hypotonia.

Authors:  Esther R Berko; Megan T Cho; Christine Eng; Yunru Shao; David A Sweetser; Jessica Waxler; Nathaniel H Robin; Fallon Brewer; Sandra Donkervoort; Payam Mohassel; Carsten G Bönnemann; Martin Bialer; Christine Moore; Lynne A Wolfe; Cynthia J Tifft; Yufeng Shen; Kyle Retterer; Francisca Millan; Wendy K Chung
Journal:  J Med Genet       Date:  2016-07-07       Impact factor: 6.318

4.  De novo FZR1 loss-of-function variants cause developmental and epileptic encephalopathies.

Authors:  Sathiya N Manivannan; Jolien Roovers; Noor Smal; Candace T Myers; Dilsad Turkdogan; Filip Roelens; Oguz Kanca; Hyung-Lok Chung; Tasja Scholz; Katharina Hermann; Tatjana Bierhals; Hande S Caglayan; Hannah Stamberger; Heather Mefford; Peter de Jonghe; Shinya Yamamoto; Sarah Weckhuysen; Hugo J Bellen
Journal:  Brain       Date:  2022-06-03       Impact factor: 15.255

5.  Loss of the neurodevelopmental gene Zswim6 alters striatal morphology and motor regulation.

Authors:  David J Tischfield; Dave K Saraswat; Andrew Furash; Stephen C Fowler; Marc V Fuccillo; Stewart A Anderson
Journal:  Neurobiol Dis       Date:  2017-04-19       Impact factor: 5.996

6.  NEDD4-like ubiquitin ligase 2 protein (NEDL2) in porcine spermatozoa, oocytes, and preimplantation embryos and its role in oocyte fertilization†.

Authors:  Jiude Mao; Michal Zigo; Dalen Zuidema; Miriam Sutovsky; Peter Sutovsky
Journal:  Biol Reprod       Date:  2021-01-04       Impact factor: 4.161

7.  DRG1 Maintains Intestinal Epithelial Cell Junctions and Barrier Function by Regulating RAC1 Activity in Necrotizing Enterocolitis.

Authors:  Li Lu; Weijue Xu; Jiangbin Liu; Liping Chen; Shaohua Hu; Qingfeng Sheng; Minghua Zhang; Zhibao Lv
Journal:  Dig Dis Sci       Date:  2021-01-20       Impact factor: 3.199

8.  Mutations in HECW2 are associated with intellectual disability and epilepsy.

Authors:  Jonatan Halvardson; Jin J Zhao; Ammar Zaghlool; Christian Wentzel; Patrik Georgii-Hemming; Else Månsson; Helena Ederth Sävmarker; Göran Brandberg; Cecilia Soussi Zander; Ann-Charlotte Thuresson; Lars Feuk
Journal:  J Med Genet       Date:  2016-06-22       Impact factor: 6.318

9.  NEDL2 regulates enteric nervous system and kidney development in its Nedd8 ligase activity-dependent manner.

Authors:  Xiao Qiu; Rongfei Wei; Yang Li; Qiong Zhu; Cong Xiong; Yuhan Chen; Yuan Zhang; Kefeng Lu; Fuchu He; Lingqiang Zhang
Journal:  Oncotarget       Date:  2016-05-24

10.  DRG1 is a potential oncogene in lung adenocarcinoma and promotes tumor progression via spindle checkpoint signaling regulation.

Authors:  Li Lu; Yanrong Lv; Ji Dong; Shaohua Hu; Ruiyun Peng
Journal:  Oncotarget       Date:  2016-11-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.